Literature DB >> 25023085

Prevalence of the β(S) gene among scheduled castes, scheduled tribes and other backward class groups in Central India.

Anuradha V Shrikhande1, Aishwarya Arjunan, Amit Agarwal, Aarti Dani, Jayashri Tijare, Elizabeth Gettig, Lakshmanan Krishnamurti.   

Abstract

Sickle cell disease is an inherited disorder of the blood, and characterized by vasoocclusive crises (VOC), risks for pneumococcal infections and organ toxicities, is associated with morbidity and premature mortality. India, with a population of 1.2 billion individuals, is estimated to be home to over 50.0% of the world's patients with sickle cell disease. The β(S) gene [β6(A3)Glu→Val; HBB: c.20A>T] has the highest prevalence in three socio-economically disadvantaged ethnic categories: the Scheduled Castes (SC), the Scheduled Tribes (ST), and Other Backward Class (OBC) groups in India. The tradition of endogamy practiced by the ethnic groups in India provides the rationale for the screening of individual populations to better understand the distribution of the β(S) gene, guide counseling and awareness programs and aid development of public policy. We undertook a study to describe the prevalence of the β(S) gene in these ethnic groups in the district of Nagpur, Maharashtra in Central India. Through community screening and subsequent targeted screening of high risk individuals, 35,636 individuals were screened, of whom 5466 were found to have sickle cell trait and 1010 were identified with sickle cell disease. Community screening revealed a sickle cell trait prevalence of 13.0% in the SC, 12.0% in the ST and 3.4% in the OBC population. This study describes the prevalence of the β(S) gene within these groups in Central India determined by large scale community screening. This program has uncovered previously undiagnosed cases, provided detailed information to guide population-based disease counseling, prevention and comprehensive care programs.

Entities:  

Keywords:  Central India; Scheduled Castes; Scheduled Tribes; sickle cell disease; βS gene

Mesh:

Substances:

Year:  2014        PMID: 25023085     DOI: 10.3109/03630269.2014.931287

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Identification of the hot-spot areas for sickle cell disease using cord blood screening at a district hospital: an Indian perspective.

Authors:  Sujata Dixit; Pushpansu Sahu; Shantanu Kumar Kar; Sapna Negi
Journal:  J Community Genet       Date:  2015-04-10

2.  Evaluation of Paper-Based Point of Care Screening Test for Sickle Cell Disease.

Authors:  Ravindra Kumar; Sweta Mishra; Anil Gwal; Rajasubramaniam Shanmugam
Journal:  Indian J Clin Biochem       Date:  2021-02-08

3.  The spatial epidemiology of sickle-cell anaemia in India.

Authors:  Carinna Hockham; Samir Bhatt; Roshan Colah; Malay B Mukherjee; Bridget S Penman; Sunetra Gupta; Frédéric B Piel
Journal:  Sci Rep       Date:  2018-12-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.